title: Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis?
authors.affiliation: Hospital of Saint Raphael, New Haven, Connecticut 06511, USA. ahansson@comcast.net
authors.forename: Joni H
authors.initials: JH
authors.lastname: Hansson
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D055499:Catheter-Related Infections / Q000188:drug therapy*; D002437:Cefazolin / Q000627:therapeutic use*; D006801:Humans; D010530:Peritoneal Dialysis; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002437:Cefazolin